PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Biomerieux SA (BIM.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0013280286
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap€11.76B
EPS€3.01
PE Ratio33.07
PEG Ratio2.90
Revenue (TTM)€3.67B
Gross Profit (TTM)€2.01B
EBITDA (TTM)€857.80M
Year Range€84.54 - €108.90
Target Price€113.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Biomerieux SA

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Biomerieux SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
16.20%
21.02%
BIM.PA (Biomerieux SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

Biomerieux SA had a return of 0.10% year-to-date (YTD) and 6.05% in the last 12 months. Over the past 10 years, Biomerieux SA had an annualized return of 14.92%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.


PeriodReturnBenchmark
Year-To-Date0.10%6.33%
1 month0.10%-2.81%
6 months14.85%21.13%
1 year6.05%24.56%
5 years (annualized)8.13%11.55%
10 years (annualized)14.92%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-0.60%1.10%1.14%
2023-3.95%-1.44%9.13%1.86%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIM.PA is 57, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of BIM.PA is 5757
Biomerieux SA(BIM.PA)
The Sharpe Ratio Rank of BIM.PA is 6060Sharpe Ratio Rank
The Sortino Ratio Rank of BIM.PA is 5353Sortino Ratio Rank
The Omega Ratio Rank of BIM.PA is 5252Omega Ratio Rank
The Calmar Ratio Rank of BIM.PA is 5858Calmar Ratio Rank
The Martin Ratio Rank of BIM.PA is 6363Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Biomerieux SA (BIM.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BIM.PA
Sharpe ratio
The chart of Sharpe ratio for BIM.PA, currently valued at 0.31, compared to the broader market-2.00-1.000.001.002.003.000.31
Sortino ratio
The chart of Sortino ratio for BIM.PA, currently valued at 0.61, compared to the broader market-4.00-2.000.002.004.006.000.61
Omega ratio
The chart of Omega ratio for BIM.PA, currently valued at 1.07, compared to the broader market0.501.001.501.07
Calmar ratio
The chart of Calmar ratio for BIM.PA, currently valued at 0.18, compared to the broader market0.001.002.003.004.005.006.000.18
Martin ratio
The chart of Martin ratio for BIM.PA, currently valued at 1.16, compared to the broader market0.0010.0020.0030.001.16
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.91, compared to the broader market-2.00-1.000.001.002.003.001.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.77, compared to the broader market-4.00-2.000.002.004.006.002.77
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.46, compared to the broader market0.001.002.003.004.005.006.001.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market0.0010.0020.0030.007.61

Sharpe Ratio

The current Biomerieux SA Sharpe ratio is 0.31. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.31
2.33
BIM.PA (Biomerieux SA)
Benchmark (^GSPC)

Dividends

Dividend History

Biomerieux SA granted a 0.84% dividend yield in the last twelve months. The annual payout for that period amounted to €0.85 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€0.85€0.85€0.85€0.62€0.19€0.35€0.34€0.33€0.33€0.33€0.33€0.33

Dividend yield

0.84%0.84%0.87%0.50%0.16%0.44%0.59%0.45%0.70%0.91%1.17%1.28%

Monthly Dividends

The table displays the monthly dividend distributions for Biomerieux SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024€0.00€0.00€0.00
2023€0.00€0.00€0.00€0.00€0.00€0.85€0.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00€0.00€0.00€0.00€0.85€0.00€0.00€0.00€0.00€0.00€0.00
2021€0.00€0.00€0.00€0.00€0.00€0.62€0.00€0.00€0.00€0.00€0.00€0.00
2020€0.00€0.00€0.00€0.00€0.00€0.00€0.19€0.00€0.00€0.00€0.00€0.00
2019€0.00€0.00€0.00€0.00€0.00€0.35€0.00€0.00€0.00€0.00€0.00€0.00
2018€0.00€0.00€0.00€0.00€0.00€0.34€0.00€0.00€0.00€0.00€0.00€0.00
2017€0.00€0.00€0.00€0.00€0.00€0.33€0.00€0.00€0.00€0.00€0.00€0.00
2016€0.00€0.00€0.00€0.00€0.00€0.33€0.00€0.00€0.00€0.00€0.00€0.00
2015€0.00€0.00€0.00€0.00€0.00€0.33€0.00€0.00€0.00€0.00€0.00€0.00
2014€0.00€0.00€0.00€0.00€0.00€0.33€0.00€0.00€0.00€0.00€0.00€0.00
2013€0.33€0.00€0.00€0.00€0.00€0.00€0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%0.8%
Biomerieux SA has a dividend yield of 0.84%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%28.2%
Biomerieux SA has a payout ratio of 28.24%, which is quite average when compared to the overall market. This suggests that Biomerieux SA strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-28.00%
-2.88%
BIM.PA (Biomerieux SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Biomerieux SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biomerieux SA was 43.56%, occurring on Sep 29, 2022. The portfolio has not yet recovered.

The current Biomerieux SA drawdown is 28.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-43.56%Oct 13, 2020507Sep 29, 2022
-40.98%Jul 15, 2010370Dec 16, 2011755Dec 1, 20141125
-37.62%Jan 3, 2008199Oct 10, 2008262Oct 21, 2009461
-35.16%Jun 15, 2018142Jan 3, 2019229Nov 25, 2019371
-21.01%Jan 11, 201839Mar 6, 201867Jun 12, 2018106

Volatility

Volatility Chart

The current Biomerieux SA volatility is 11.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
11.11%
3.38%
BIM.PA (Biomerieux SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Biomerieux SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items